Discover the iCAD Virtual Experience
Access the critical information you need, wherever you are, despite the COVID-19 pandemic
ProFound AI
Discover the ProFound impact of artificial intelligence for digital breast tomosynthesis
FDA Cleared, CE Marked, Health Canada Licensed
ProFound AI for 2D Mammography - EU
World-class artificial intelligence for 2D mammography
CE Mark Approved, not available for sale in the United States
<
>
About iCAD
iCAD is a global leader in advanced breast cancer detection solutions built on artificial intelligence that empower radiologists to find cancers earlier while improving reading workflow. Our Breast Health Solutions suite delivers powerful detection and workflow solutions for 2D and 3D mammography.
How is breast cancer screening and treatment evolving in the era of COVID-19?
In partnership with:
If you were unable to attend our Virtual Roundtable Event, “How is breast cancer screening and treatment evolving in the era of COVID-19”, access the recording below.
iCAD’s Response to COVID-19
Read our response to COVID-19 and learn how our portfolio of solutions supporting cancer detection and therapy continue to offer significant benefits to clinicians, patients and the overall healthcare system.
From the Newsroom
June 1, 2020
iCAD Hosts Virtual Roundtable Event on Breast Cancer Surgery and Targeted Radiation During COVID-19
May 11, 2020
iCAD Reports First Quarter 2020 Financial Results
May 5, 2020
iCAD to Report First Quarter 2020 Financial Results on Monday, May 11
April 23, 2020
iCAD Announces Pricing of $12.5 Million Registered Direct Offering
April 13, 2020
iCAD Partners with the TME Breast Care Network to Host Virtual Event: Breast Care Roundtable in the Age of COVID-19
» View all news »
Discover the Power of ProFound AI™ for Digital Breast Tomosynthesis
Digital breast tomosynthesis (DBT) is rapidly replacing 2D mammography in breast cancer screening because of the clinical value it offers in cancer detection. However, it presents significant workload challenges for radiologists, which can affect patient care. ProFound AI™ is clinically proven to assist radiologists by improving cancer detection, decreasing reading times and reducing false positives and costly patient recalls.
iNFORMED - Blog
Inform, connect and engage. We invite you to engage with us to participate on the topic of cancer detection solutions, patient stories, clinical expertise.
Customer Spotlight
From Surviving to Thriving: How Regional Medical Imaging Enhanced Productivity and Profitability with ProFound AI™ for Digital Breast Tomosynthesis
Clinical Feature
Improving reading time of digital breast tomosynthesis with concurrent computer aided detection.
Supporting cancer detection for 3,500+ healthcare facilities worldwide
Speak to a specialist today at 1.866.280.2239
Resources
Precise and Powerful Healthcare Solutions
© 2019, iCAD Inc. All rights reserved. iCAD, the iCAD logo,, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.
